vs
Side-by-side financial comparison of AGENUS INC (AGEN) and Armour Residential REIT, Inc. (ARR). Click either name above to swap in a different company.
Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $34.2M, roughly 1.5× AGENUS INC). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -31.0%, a 451.3% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 27.5%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs 10.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
AGEN vs ARR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $50.4M |
| Net Profit | $-10.6M | $211.7M |
| Gross Margin | — | — |
| Operating Margin | 42.1% | — |
| Net Margin | -31.0% | 420.2% |
| Revenue YoY | 27.5% | 297.9% |
| Net Profit YoY | 77.3% | 555.9% |
| EPS (diluted) | $0.09 | $2.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $50.4M | ||
| Q3 25 | $30.2M | $38.5M | ||
| Q2 25 | $25.7M | $33.1M | ||
| Q1 25 | $24.1M | $36.3M | ||
| Q4 24 | $26.8M | $12.7M | ||
| Q3 24 | $25.1M | — | ||
| Q2 24 | $23.5M | $7.0M | ||
| Q1 24 | $28.0M | — |
| Q4 25 | $-10.6M | $211.7M | ||
| Q3 25 | $63.9M | $159.3M | ||
| Q2 25 | $-30.0M | $-75.6M | ||
| Q1 25 | $-26.4M | $27.3M | ||
| Q4 24 | $-46.8M | $-46.4M | ||
| Q3 24 | $-67.2M | — | ||
| Q2 24 | $-54.8M | $-48.4M | ||
| Q1 24 | $-63.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — | ||
| Q1 24 | 99.6% | — |
| Q4 25 | 42.1% | — | ||
| Q3 25 | -15.0% | — | ||
| Q2 25 | -65.0% | — | ||
| Q1 25 | -55.3% | — | ||
| Q4 24 | -96.5% | — | ||
| Q3 24 | -125.5% | — | ||
| Q2 24 | -128.4% | — | ||
| Q1 24 | -117.4% | — |
| Q4 25 | -31.0% | 420.2% | ||
| Q3 25 | 211.4% | 413.5% | ||
| Q2 25 | -116.8% | -228.4% | ||
| Q1 25 | -109.6% | 75.2% | ||
| Q4 24 | -174.4% | -366.8% | ||
| Q3 24 | -267.7% | — | ||
| Q2 24 | -233.1% | -693.8% | ||
| Q1 24 | -226.6% | — |
| Q4 25 | $0.09 | $2.43 | ||
| Q3 25 | $1.94 | $1.49 | ||
| Q2 25 | $-1.00 | $-0.94 | ||
| Q1 25 | $-1.03 | $0.32 | ||
| Q4 24 | $-1.95 | $-0.91 | ||
| Q3 24 | $-3.08 | — | ||
| Q2 24 | $-2.52 | $-1.05 | ||
| Q1 24 | $-3.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $63.3M |
| Total DebtLower is stronger | $44.7M | — |
| Stockholders' EquityBook value | $-271.1M | $2.3B |
| Total Assets | $226.8M | $21.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $63.3M | ||
| Q3 25 | $3.5M | $44.2M | ||
| Q2 25 | $9.5M | $141.2M | ||
| Q1 25 | $18.5M | $49.1M | ||
| Q4 24 | $40.4M | $68.0M | ||
| Q3 24 | $44.8M | — | ||
| Q2 24 | $93.7M | $126.6M | ||
| Q1 24 | $52.9M | — |
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-271.1M | $2.3B | ||
| Q3 25 | $-274.1M | $2.1B | ||
| Q2 25 | $-354.6M | $1.7B | ||
| Q1 25 | $-341.8M | $1.7B | ||
| Q4 24 | $-326.4M | $1.4B | ||
| Q3 24 | $-292.3M | — | ||
| Q2 24 | $-241.3M | $1.2B | ||
| Q1 24 | $-201.4M | — |
| Q4 25 | $226.8M | $21.0B | ||
| Q3 25 | $233.9M | $19.4B | ||
| Q2 25 | $185.2M | $16.2B | ||
| Q1 25 | $200.2M | $15.5B | ||
| Q4 24 | $226.3M | $13.5B | ||
| Q3 24 | $238.5M | — | ||
| Q2 24 | $292.4M | $10.1B | ||
| Q1 24 | $256.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $124.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 0.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $124.2M | ||
| Q3 25 | $-14.7M | $-37.8M | ||
| Q2 25 | $-20.2M | $25.0M | ||
| Q1 25 | $-25.6M | $101.5M | ||
| Q4 24 | $-28.7M | $261.5M | ||
| Q3 24 | $-53.3M | — | ||
| Q2 24 | $-38.2M | $27.1M | ||
| Q1 24 | $-38.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-20.2M | — | ||
| Q1 25 | $-25.6M | — | ||
| Q4 24 | $-28.7M | — | ||
| Q3 24 | $-53.3M | — | ||
| Q2 24 | $-38.6M | — | ||
| Q1 24 | $-38.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -78.7% | — | ||
| Q1 25 | -106.5% | — | ||
| Q4 24 | -107.0% | — | ||
| Q3 24 | -212.2% | — | ||
| Q2 24 | -164.4% | — | ||
| Q1 24 | -136.5% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 0.59× | ||
| Q3 25 | -0.23× | -0.24× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
ARR
Segment breakdown not available.
